Viewing Study NCT00003993


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2025-12-31 @ 7:59 PM
Study NCT ID: NCT00003993
Status: COMPLETED
Last Update Posted: 2015-04-29
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma
Sponsor: National Institute on Aging (NIA)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: CDR0000067198
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View